Stay updated on Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe only visible change is the revision tag updating from v3.4.1 to v3.4.2, with no changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedA new site revision (v3.4.1) was added and the previous revision (v3.4.0) was removed.SummaryDifference0.1%

- Check33 days agoChange DetectedThe page now shows 'Results First Posted' and 'Last Update Posted' dates, replacing the previous 'Estimated' indicators for results and updates.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page revision label was updated to Revision: v3.3.4 and the previous Revision: v3.3.3 was removed. This is a metadata update and does not modify study content.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page now lists a New York location under Locations, expanding visibility of where the study is conducted. The previous 'New York Locations' entry has been removed and the revision updated to v3.3.3.SummaryDifference0.2%

- Check76 days agoChange DetectedResults have been posted, including the number of participants with response and toxicity data, along with associated results submission dates. A PDF of the Study Protocol and Statistical Analysis Plan has been added under Study Documents.SummaryDifference1%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page.